Wall Street analysts forecast that Liquidia Co. (NASDAQ:LQDA – Get Rating) will announce sales of $3.37 million for the current quarter, according to Zacks. Three analysts have made estimates for Liquidia’s earnings, with the highest sales estimate coming in at $3.80 million and the lowest estimate coming in at $3.10 million. Liquidia reported sales of […]
Analysts expect Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) to post earnings per share (EPS) of ($0.13) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Fennec Pharmaceuticals’ earnings. Fennec Pharmaceuticals posted earnings of ($0.18) per share during the same quarter last year, which suggests a positive year over […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Accuray (NASDAQ:ARAY – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday. ARAY stock opened at $2.83 on Thursday. The company has a market cap of $262.44 million, a PE ratio of -21.77 and a beta of 1.91. The […]
Analysts forecast that TransAct Technologies Incorporated (NASDAQ:TACT – Get Rating) will post sales of $11.48 million for the current quarter, Zacks reports. Two analysts have issued estimates for TransAct Technologies’ earnings. The highest sales estimate is $11.85 million and the lowest is $11.10 million. TransAct Technologies posted sales of $8.30 million during the same quarter […]